Streetbeat News

Products Services

AXNX

IFRX

LHDX

NERV

PRAX

The biotech sector saw significant developments, including Minerva's positive Phase 3 trial results for schizophrenia treatment, InflaRx's promising Phase 2 study results for vasculitis treatment, and Lucira's COVID-19 test kit availability on Amazon. Stocks like Minerva and InflaRx experienced price increases, while Praxis and Axonics saw declines due to public offerings.

Portfolio Pulse from Shanthi Rexaline

May 12, 2021 | 12:57 pm

DSKE

GOEV

HCIC

NAV

TSP

Plus, a self-driving truck software developer, is merging with SPAC Hennessey Capital V, bringing $500 million in cash and a $3.3 billion valuation. The deal is expected to close in Q3. Meanwhile, TuSimple, a rival in autonomous trucking, received new analyst coverage with potential growth projections.

Portfolio Pulse from FreightWaves

May 10, 2021 | 4:13 pm

DGLY

Digital Ally shares increased as the company reiterated its earlier announcement of securing multiple contracts for body-worn and in-car camera systems.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2021 | 4:09 pm

DKNG

FUBO

MGM

Leicester City faces Newcastle United in a Premier League match on May 7. Leicester is in strong form, while Newcastle is struggling. The match can be streamed on fuboTV, and betting odds are provided by Bovada, MGM Resorts, and DraftKings.

Portfolio Pulse from Henry Khederian

May 07, 2021 | 4:03 pm

BZ

Benzinga Pro has launched a live PreMarket Prep session, accessible via their chat tool. This service is likely aimed at providing investors with timely market insights before the trading day begins.

Portfolio Pulse from Zoltan Suranyi

May 04, 2021 | 12:00 pm

EBAY

eBay's CEO announced that the company is exploring opportunities to enable the selling of non-fungible tokens (NFTs) on its platform. This move could position eBay as a significant player in the growing NFT market.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2021 | 2:44 pm

AVRO

AVROBIO has provided a regulatory update on its investigational gene therapy, AVR-RD-01, for Fabry disease. This update is crucial for investors as it may impact the company's future prospects and stock performance.

Portfolio Pulse from Luke J Jacobi

May 03, 2021 | 11:07 am

CLOV

Clover Health's stock surged over 21% on Wednesday, breaking through resistance levels, driven by bullish options trading and technical indicators. The stock has been heavily shorted and is expected to rebound further with upcoming earnings on May 17.

Portfolio Pulse from Melanie Schaffer

April 28, 2021 | 8:50 pm

NIO

XPEV

NIO Inc. (NYSE: NIO) has confirmed its European expansion plan, starting with Norway, and its stock is up in premarket trading. The company will hold a press conference on May 6 to discuss its plans. NIO aims to strengthen its global presence, with existing operations in Germany and the UK. The expansion into Europe is seen as a logical step to increase market share.

Portfolio Pulse from Shanthi Rexaline

April 28, 2021 | 11:09 am

BCCEF

BacTech Environmental Corporation has signed a Memorandum of Understanding with Curatio Gold Limited to process refractory ores from Eastern Africa, aiming to reduce mercury use in gold mining. The agreement could lead to new revenue streams and improved environmental practices in the region.

Portfolio Pulse from The Newswire

April 26, 2021 | 12:50 pm